Australian Researchers Develop Low-Cost Method for Low-Calorie Rare Sugar Using Genetically Modified Techniques

Australian biotechnology researchers have developed a cost-effective method to produce allulose, a low-calorie “rare sugar,” using genetically engineered microorganisms. This breakthrough aims to lower the high production costs that currently prevent allulose from becoming a mainstream alternative to sucrose in the global food market.

The new process utilizes metabolic engineering to transform common sugars into allulose through microbial fermentation. By modifying the genetic pathways of specific microbes, scientists can facilitate a more direct and efficient conversion process than current enzymatic methods, which often rely on expensive raw materials and complex extraction techniques.

Allulose is a monosaccharide that occurs naturally in very small quantities in foods like figs and raisins. While it provides a taste and texture profile similar to table sugar, it contains approximately 70% of the sweetness and nearly zero calories, making it a high-interest target for the food and beverage industry’s efforts to reduce sugar consumption.

How metabolic engineering enables rare sugar production

Traditional production of allulose typically involves the enzymatic conversion of fructose, a process that can be expensive and resource-intensive. According to researchers working in the field of biotechnology, the cost of these enzymes and the specific feedstock required often limit the scalability of allulose for mass-market consumer goods.

The Australian research approach shifts the focus toward microbial fermentation. By using genetic engineering, scientists can program microorganisms, such as specialized strains of bacteria or yeast, to consume glucose and excrete allulose as a metabolic byproduct. This method is expected to be significantly more scalable because it utilizes glucose, one of the most abundant and inexpensive carbon sources available.

This technique involves precisely altering the metabolic pathways within the cell to ensure that the energy from the glucose is directed toward the synthesis of allulose rather than other cellular components. This precision reduces waste and increases the overall yield of the desired sugar, which is a critical factor in driving down market prices.

Why allulose is categorized as a “rare sugar”

In food science, “rare sugars” refer to monosaccharides that are found in nature in extremely low concentrations. While these sugars often possess unique functional properties—such as specific sweetness levels or low glycemic impacts—their scarcity makes them difficult to harvest from natural sources in quantities sufficient for industrial use.

Allulose is particularly valued because it does not significantly impact blood glucose or insulin levels. Unlike sucrose, which the body metabolizes into glucose, allulose is largely absorbed in the small intestine but not metabolized for energy, allowing it to pass through the system without the caloric load associated with traditional sweeteners.

The ability to mass-produce these rare molecules through synthetic biology represents a shift in how the food industry approaches ingredient sourcing. Rather than relying on the limited availability of natural extracts, manufacturers can use controlled biological environments to “grow” specific ingredients on demand.

Comparing allulose to common sugar alternatives

To understand the potential market impact, it is necessary to compare allulose with existing sugar substitutes used in the food industry. While sweeteners like erythritol and stevia are widely available, allulose offers a unique combination of taste and functional characteristics.

As shown in the comparison, allulose provides a “bulking” capability that many high-intensity sweeteners, such as stevia, lack. This makes it more effective for baking and confectionery applications where the physical structure of the food depends on the presence of a crystalline or liquid sugar.

The economic implications for the food and beverage industry

The global food industry is currently facing increased pressure from both regulators and consumers to reduce added sugars in processed foods. However, replacing sugar is technically difficult because sugar contributes to more than just sweetness; it affects texture, browning (via the Maillard reaction), and shelf stability.

The current high price of allulose has made it a “premium” ingredient, largely restricted to niche health food products. If the Australian researchers’ method successfully reduces production costs through large-scale fermentation, allulose could move from a specialty ingredient to a commodity sweetener.

Lower costs would allow major food manufacturers to reformulate a wider range of products—including sodas, yogurts, and baked goods—to meet new health standards without significantly increasing the retail price for consumers. This shift could have a widespread impact on the management of metabolic health conditions like obesity and type 2 diabetes globally.

Industry analysts suggest that the success of this technology depends on the efficiency of the microbial strains and the ability to maintain high purity levels during the downstream processing stages. As the biotechnology sector continues to refine these fermentation protocols, the availability of low-calorie, functional sweeteners is expected to increase.

The next milestone for this research involves scaling the microbial fermentation process from laboratory-sized bioreactors to industrial-scale production facilities to confirm cost-efficiency at volume. We will continue to monitor official updates from biotechnology research institutions regarding pilot program results.

What are your thoughts on the use of genetically engineered microbes to create food ingredients? Share your comments below and share this article with your network.